Novartis Gains FDA Approval For Tafinlar And Mekinist Administered Together

09:29 EDT 7 May 2018 | Pharmaceutical Processing

News

FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer.

Contributed Author:

The U.S. Food & Drug Administration

Topics:

More From BioPortfolio on "Novartis Gains FDA Approval For Tafinlar And Mekinist Administered Together"